Novo Nordisk A/S ADR buy gerihouse
Start price
04.04.24
/
90%
€117.00
Target price
04.04.25
€140.00
Performance (%)
-52.91%
End price
05.04.25
€55.10
Summary
This prediction ended on 05.04.25 with a price of €55.10. The BUY prediction by gerihouse for Novo Nordisk A/S ADR performed very badly with a performance of -52.91%. A total of €1.56 was paid as dividends for this prediction. gerihouse has 90% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 0.150% | 0.150% | -52.699% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% |
According to gerihouse what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Small cyclical dependencies
Known brand
Cons
Comments by gerihouse for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 140,0
In the thread Trading Novo Nordisk A/S ADR
Die von gerihouse gewählte maximale Laufzeit wurde überschritten
Stopped prediction by gerihouse for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.39
30.08.16
30.08.16
€50.00
02.02.17
02.02.17
-25.03%
02.02.17
02.02.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Small cyclical dependencies
